Skip to main content

Undernutrition

1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
ImpactPhase 41 trial
Active Trials
NCT00559520Completed250Est. Dec 2011
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
2 programs
Nutritional telemonitoringN/A1 trial
Nutritional telemonitoringN/A1 trial
Active Trials
NCT03240094Completed213Est. May 2017
NCT03211845Completed20Est. Nov 2015
Novartis
NovartisBASEL, Switzerland
1 program
ImpactPHASE_41 trial
Active Trials
NCT02444390Completed150Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozImpact
UNION therapeuticsNutritional telemonitoring
UNION therapeuticsNutritional telemonitoring
NovartisImpact

Clinical Trials (4)

Total enrollment: 633 patients across 4 trials

NCT00559520SandozImpact

The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery

Start: Feb 2002Est. completion: Dec 2011250 patients
Phase 4Completed
NCT03240094UNION therapeuticsNutritional telemonitoring

Feasibility and Effectiveness of Nutritional Telemonitoring in Community-dwelling Elderly.

Start: Feb 2016Est. completion: May 2017213 patients
N/ACompleted
NCT03211845UNION therapeuticsNutritional telemonitoring

Feasibility of Nutritional Telemonitoring in Elderly Home Care Patients

Start: May 2015Est. completion: Nov 201520 patients
N/ACompleted
NCT02444390NovartisImpact

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

Start: May 2015Est. completion: Jul 2022150 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.